Excitotoxicity, a major pathophysiological mechanism of many neurological disorders, is mediated by a specific type of glutamate receptor, the n-methyl-D-aspartate (NMDA) receptor. Understanding NMDA receptor activation is crucial for developing therapeutic strategies which block excitotoxicity. The NMDA receptor is present in brain as many different subtypes, which differ in composition by the type of subunits which are present. The endogenous enzyme protein kinase C modulates NMDA receptor function heterogeneously in the brain, perhaps reflecting varying composition of NMDA receptors. In heterologous expression systems, the two types of NMDA receptor subunits (NR 1 and NR2) subunit contribute differently to modulation by PKC. In the present study, we will determine the mechanisms by which such modulation occurs and whether findings in heterologous systems explain the diversity of effects of PKC found in the brain. In the first aim, we will use biochemical and molecular biological approaches to determine the exact site or sites on the NR2A subunit which are phosphorylated by PKC. This will begin with phosphorylation experiments in vitro. Site directed mutations will allow determination of whether these sites are causally linked with NR 2A-dependent potentiation of NMDA receptors by PKC. In the second aim we will ascertain the cellular mechanism which mediates NR1 dependent attenuation of NMDA receptors by PKC. Specific experiments will examine the effects of agents which alter calmodulin, actin, and intermediate filaments, all of which interact with NR 1 in subtype specific manners. In our third aim we will determine whether the cell specific effects of PKC on native NMDA receptors reflect cell specific differences in the type of NMDA receptors which are made. These experiments will use measurements of the effect of PKC on NMDA receptors of single cells, and use RNA amplification techniques to determine which NMDA receptors mRNAs are made in those specific cells. The type of NMDA receptor mRNAs made will be correlated quantitatively with the cellular response. In our final aim we will use a model of excitotoxicity to determine the role which PKC plays in potentiation or inhibition of NMDA receptor mediated excitotoxicity. This systematic approach should provide critical information on the complete mechanisms of control of NMDA receptors by PKC and their significance in physiologic and pathophysiologic processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS039126-04
Application #
6529438
Study Section
Special Emphasis Panel (ZRG1-MDCN-2 (01))
Program Officer
Tagle, Danilo A
Project Start
1999-08-16
Project End
2004-07-31
Budget Start
2002-08-01
Budget End
2004-07-31
Support Year
4
Fiscal Year
2002
Total Cost
$248,194
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Baybis, Marianna; Lynch, David; Lee, Allana et al. (2004) Altered expression of neurotransmitter-receptor subunit and uptake site mRNAs in hemimegalencephaly. Epilepsia 45:1517-24
Dong, Yi Na; Waxman, Elisa A; Lynch, David R (2004) Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J Neurosci 24:11035-45
Mishizen-Eberz, Amanda J; Guttmann, Rodney P; Giasson, Benoit I et al. (2003) Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro. J Neurochem 86:836-47
Simpkins, Kelly L; Guttmann, Rodney P; Dong, Yina et al. (2003) Selective activation induced cleavage of the NR2B subunit by calpain. J Neurosci 23:11322-31
Lynch, David R; Farmer, Jennifer M; Balcer, Laura J et al. (2002) Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. Arch Neurol 59:743-7
Lynch, David R; Guttmann, Rodney P (2002) Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J Pharmacol Exp Ther 300:717-23
Guttmann, Rodney P; Sokol, Set; Baker, Dana L et al. (2002) Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J Pharmacol Exp Ther 302:1023-30
Lynch, David R; Farmer, Jennifer M (2002) Neurogenetics. Introduction. Neurol Clin 20:xi-xii
Lynch, D R; Guttmann, R P (2001) NMDA receptor pharmacology: perspectives from molecular biology. Curr Drug Targets 2:215-31
Raol, Y H; Lynch, D R; Brooks-Kayal, A R (2001) Role of excitatory amino acids in developmental epilepsies. Ment Retard Dev Disabil Res Rev 7:254-60

Showing the most recent 10 out of 12 publications